Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Enfuvirtide
Updated on : August - 2012
Latest prescription information about Enfuvirtide. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
|
Generic Name : Enfuvirtide
Pronunciation : en-FUE-vir-tide
Therapeutic Classification : Antivirals
ICD Code : Y41.5
♦ Safety Labeling Changes Approved By FDA
Trade Name(s): International- Fuzeon. Why it is prescribed (Indications) : This medication is an antiretroviral agent, prescribed for HIV/AIDS. It works by decreasing the amount of HIV in the blood. When it is not to be taken (Contraindications): Hypersensitivity.
Dosage & When it is to be taken : SC: Adult- The recommended dose is 90 mg (1 ml) twice daily. How it should be taken : It comes as a solution for injection, to be administered by a healthcare provider subcutaneously (under the skin). Warnings and Precautions : * Caution should be exercised in patients with history of blood clot or bleeding problems, smoking, lung disease, any allergy, during pregnancy and lactation. * It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication. * Do not use contaminated fluid of this medication. * Avoid sexual contact, sharing of needles to prevent the spread of infection. ♦ *Patient may develop Immune Reconstitution Syndrome. Side Effects : Local- Pain/discomfort, in duration, redness, lesions, itching and scars. Genitourinary- Kidney failure/inflammation. Blood- Decrease in blood cells. Metabolic- Increased sugar level, infections and weight loss. Central Nervous System- Taste disturbances, paralysis and loss of reflexes, include numbness, weakness, burning pain, depression, anxiety and suicide attempt. Heart- Heart attack. Gastrointestinal - Constipation, abdominal pain, loss of appetite and dry mouth. Liver- Liver inflammation/damage Respiratory- Lung disease, respiratory distress and cough. * Monitor complete blood counts, liver and kidney function during the treatment. Storage Conditions : Store it at room temperature (25°C), and in an airtight container. |
 Comment & Contribute
| ||
Browse the Drugs alphabetically
Reference
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- PubMed
- CIMS
- Indian Pharma Reference Guide 2012
Drugs Index
Pharma Links 
Recently added Drugs
Quick Links
Ask an Expert
